Literature DB >> 19815500

Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Andreas C Joerger1, Sridharan Rajagopalan, Eviatar Natan, Dmitry B Veprintsev, Carol V Robinson, Alan R Fersht.   

Abstract

Oligomerization of members of the p53 family of transcription factors (p53, p63, and p73) is essential for their distinct functions in cell-cycle control and development. To elucidate the molecular basis for tetramer formation of the various family members, we solved the crystal structure of the human p73 tetramerization domain (residues 351-399). Similarly to the canonical p53 tetramer, p73 forms a tetramer with D(2) symmetry that can be described as a dimer of dimers. The most striking difference between the p53 and p73 tetramerization domain is the presence of an additional C-terminal helix in p73. This helix, which is conserved in p63, is essential for stabilizing the overall architecture of the tetramer, as evidenced by the different oligomeric structures observed for a shortened variant lacking this helix. The helices act as clamps, wrapping around the neighboring dimer and holding it in place. In addition, we show by mass spectrometry that the tetramerization domains of p63 and p73, but not p53, fully exchange, with different mixed tetramers present at equilibrium, albeit at a relatively slow rate. Taken together, these data provide intriguing insights into the divergent evolution of the oligomerization domain within the p53 family, from the ancestral p63/p73-like protein toward smaller, less promiscuous monomeric building blocks in human p53, allowing functional separation of the p53 pathway from that of its family members.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815500      PMCID: PMC2764906          DOI: 10.1073/pnas.0905867106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  Structural basis for gene activation by p53 family members.

Authors:  Ariane Scoumanne; Kelly Lynn Harms; Xinbin Chen
Journal:  Cancer Biol Ther       Date:  2005-11-18       Impact factor: 4.742

3.  A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer.

Authors:  Enrico L DiGiammarino; Amanda S Lee; Craig Cadwell; Weixing Zhang; Brian Bothner; Raul C Ribeiro; Gerard Zambetti; Richard W Kriwacki
Journal:  Nat Struct Biol       Date:  2002-01

4.  A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.

Authors:  C Gaiddon; M Lokshin; J Ahn; T Zhang; C Prives
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Solution structure of the tetrameric minimum transforming domain of p53.

Authors:  W Lee; T S Harvey; Y Yin; P Yau; D Litchfield; C H Arrowsmith
Journal:  Nat Struct Biol       Date:  1994-12

6.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.

Authors:  P D Jeffrey; S Gorina; N P Pavletich
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

7.  Ultraslow oligomerization equilibria of p53 and its implications.

Authors:  Eviatar Natan; Daniel Hirschberg; Nina Morgner; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

8.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

Review 9.  On the shoulders of giants: p63, p73 and the rise of p53.

Authors:  Annie Yang; Mourad Kaghad; Daniel Caput; Frank McKeon
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

10.  Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

Authors:  Sabrina Strano; Giulia Fontemaggi; Antonio Costanzo; Maria Giulia Rizzo; Olimpia Monti; Alessia Baccarini; Giannino Del Sal; Massimo Levrero; Ada Sacchi; Moshe Oren; Giovanni Blandino
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

View more
  65 in total

1.  Identification of a novel Mcl-1 protein binding motif.

Authors:  William J Placzek; Mattia Sturlese; Bainan Wu; Jason F Cellitti; Jun Wei; Maurizio Pellecchia
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 2.  p63 and p73, the ancestors of p53.

Authors:  V Dötsch; F Bernassola; D Coutandin; E Candi; G Melino
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-19       Impact factor: 10.005

3.  Mechanisms of protein oligomerization, the critical role of insertions and deletions in maintaining different oligomeric states.

Authors:  Kosuke Hashimoto; Anna R Panchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

Review 4.  Role of the nucleus in apoptosis: signaling and execution.

Authors:  Evgeniia A Prokhorova; Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2015-09-07       Impact factor: 9.261

5.  Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain.

Authors:  Jan Heering; Hendrik R A Jonker; Frank Löhr; Harald Schwalbe; Volker Dötsch
Journal:  Protein Sci       Date:  2015-11-25       Impact factor: 6.725

Review 6.  Translating p53 into the clinic.

Authors:  Chit Fang Cheok; Chandra S Verma; José Baselga; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2010-10-26       Impact factor: 66.675

7.  p73 - constitutively open for business.

Authors:  M A Seeliger; U M Moll
Journal:  Cell Death Differ       Date:  2013-08       Impact factor: 15.828

8.  p53 suppresses CCL2-induced subcutaneous tumor xenograft.

Authors:  Xiaoren Tang; Salomon Amar
Journal:  Tumour Biol       Date:  2014-12-11

9.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

10.  Structural and Functional Highlights of Vacuolar Soluble Protein 1 from Pathogen Trypanosoma brucei brucei.

Authors:  Abhishek Jamwal; Adam R Round; Ludovic Bannwarth; Catherine Venien-Bryan; Hassan Belrhali; Manickam Yogavel; Amit Sharma
Journal:  J Biol Chem       Date:  2015-10-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.